Endo Cannabinoids

Beskrivelse

Endo Cannabinoids is a comprehensive hard copy guide exploring the four distinct types of cannabinoids: endo-cannabinoids, phyto-cannabinoids, synthetic cannabinoids, and cannabinoids derived from yeast. It’s designed for anyone interested in understanding the therapeutic potential of cannabis and the various phyto-cannabinoids.

An advanced exploration of cannabinoids and their therapeutic effects, including the “entourage effect” and medical applications.

This book, authored by Jonas Østergaard, offers an in-depth look at cannabinoid-based drugs, supplements, and dermatology. Each cannabinoid is examined individually and in combination with others to explain the so-called “entourage effect,” a concept endorsed by Dr. Raphael Mechoulam from the University of Jerusalem.

Phyto-cannabinoids, which are plant-derived molecules produced by cannabis flower trichomes, are contrasted with endo-cannabinoids-similar molecules naturally produced by the human body without cannabis consumption. Phyto-cannabinoids can be used both internally and externally and influence the production of endo-cannabinoids in the body.

Since endo-cannabinoids and their receptors appear to play roles in nearly every disease, the medical possibilities of cannabinoids are vast yet often overlooked. For example, the FDA has approved medications containing THC to alleviate nausea from chemotherapy and stimulate appetite in AIDS patients.

The book opens with a powerful quote from Hon. Francis Young, DEA Administrative Law Judge in 1988, highlighting the safety and therapeutic potential of marijuana compared to common foods. He stated that marijuana is one of the safest therapeutically active substances known and can be safely used under medical supervision.

Alongside this detailed cannabinoid guide, a CBD user guide is also included. Recent research, such as studies from the University of Nebraska and Texas Biomedical Research Institute in 2020, suggests that CBD derived from cannabis might help treat severe lung inflammation caused by coronavirus (SARS-CoV-2).

The field of cannabinoid-based pharmaceuticals is rapidly growing worldwide, with regulatory changes enabling more research and clinical use. However, many physicians remain cautious, calling for more scientific studies and education to confidently incorporate cannabis into medical practice.

Although further clinical trials are needed to fully unlock the potential of cannabinoids, current literature shows that we know more about cannabis than many other approved pharmaceutical drugs. This book can be read straight through or used as a reference, with a recommendation to start with the first four sections for the best understanding.

Yderligere information